Testicles do shrink after prostate cancer treatment, but the degree depends on the specific therapies used. Hormone therapy, known as Androgen Deprivation Therapy (ADT), is the strongest driver of this change. Radiation therapy also contributes to shrinkage, whereas surgery alone has a negligible direct effect on testicular volume.
The role of hormone therapy
ADT is frequently prescribed alongside radiation or for high-risk surgical cases. It works by suppressing testosterone production, effectively putting the testicles into a state of hibernation. Without the constant hormonal signal to maintain size and function, the testicular tissue atrophies. This process is similar to muscle loss when a limb is immobilized; the tissue shrinks because it is not being actively stimulated. For men undergoing several months of ADT, this shrinkage is nearly universal and can be quite pronounced, leaving the testicles noticeably softer and smaller.
How radiation affects size
Radiation therapy targets the prostate with high-energy beams to destroy cancer cells. While modern techniques like IMRT and SBRT are precise, some scatter radiation reaches the nearby testicles. The germ cells responsible for sperm production are highly sensitive to this radiation. As these cells are damaged or destroyed, the bulk of the testicular tissue is lost. This leads to a gradual reduction in size over months to years. Unlike the immediate effect of hormone suppression, radiation-induced shrinkage is a structural change resulting from cell loss.
Impact of surgery alone
Radical prostatectomy removes the prostate gland but leaves the testicles intact. The procedure does not directly cut off blood supply or nerve function to the testicles in a way that causes significant atrophy. Any minor changes in size after surgery alone are usually related to natural aging or general vascular changes, rather than the surgical trauma itself. Therefore, if a man has only surgery without ADT or radiation, he is unlikely to experience significant testicular shrinkage.
Reversibility and long-term outlook
Whether the shrinkage is permanent depends largely on the cause. If the size reduction is primarily due to a short course of hormone therapy, some recovery in size and function may occur after the medication stops and testosterone levels rebound. However, if ADT was used for a long duration, or if radiation was part of the treatment, the shrinkage is likely to be permanent. The loss of sperm-producing tissue from radiation cannot be regrown. Men should discuss their specific treatment plan with their oncologist to understand what to expect regarding physical changes.
Emotional and practical considerations
Physical changes to the genitals can be psychologically distressing. Many men feel embarrassed to discuss this with their medical team, assuming it is a trivial concern compared to cancer survival. In reality, urologists and oncologists are accustomed to these questions. Understanding that shrinkage is a standard physiological response to treatment, rather than a mistake or a sign of something going wrong, can help reduce anxiety. It is important to address these concerns openly to maintain a realistic perspective on body image and quality of life during and after treatment.